Qualitek Labs Q4 FY26 Share Price & Earnings Call Analysis
- Market cap
- ₹585 Cr
- P/E
- 42.57
- ROE
- 11.49%
- Price to sales
- 4.69
- Debt to equity
- 0.61
- 52W high / low
- ₹646 / ₹309
- Sales growth (5Y)
- 81.34%
- EBITDA margin
- 23.80%
- Net profit margin
- 11.83%
- Promoter holding
- 56.46%
- Sales (last year)
- ₹125 Cr
Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services.[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Commercial Services & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Commercial Services & Supplies companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹2,211 Cr | 145.7 | |
| 2 | 40%+ | Up 2%+ | ₹39 Cr | 6.2 | |
| 3 | 40%+ | Flat | ₹500 Cr | 36.0 | |
| 4 | 40%+ | Flat | ₹102 Cr | 10.4 | |
| 5 | 20–40% | Up 2%+ | ₹3,079 Cr | 36.3 | |
| 6 | 20–40% | Up 0–2% | ₹44 Cr | 3.9 |
Sign up free to see every company in the sector ranking and track Qualitek Labs.
Pro shows every company guiding 40%+ revenue growth →Full Commercial Services & Supplies rankingQualitek Labs announcements
All announcements →- Fundraise / allotmentNotableQualitek Labs approves preferential issue of equity shares and convertible warrants
Financials of Qualitek Labs
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Qualitek Labs
Quarterly Results
Quarter-by-quarter operating performance
Financials of Qualitek Labs
Profit & Loss
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales + | 6 | 12 | 70 | 125 |
| Expenses + | 6 | 11 | 54 | 95 |
| Operating Profit | 1 | 1 | 16 | 29 |
| OPM % | 11% | 10% | 23% | 24% |
| Other Income + | 0 | 0 | 1 | 0 |
| Interest | 0 | 0 | 2 | 5 |
| Depreciation | 0 | 1 | 4 | 7 |
| Profit before tax | 0 | 0 | 10 | 18 |
| Tax % | 61% | 12% | 26% | 20% |
| Net Profit + | 0 | 0 | 8 | 15 |
| EPS in Rs | 160.00 | 9.13 | 6.31 | 12.53 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
Financials of Qualitek Labs
Balance Sheet
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.01 | 0.46 | 10 | 12 |
| Reserves | -1 | 0 | 77 | 141 |
| Borrowings + | 11 | 17 | 50 | 93 |
| Other Liabilities + | 4 | 3 | 21 | 26 |
| Total Liabilities | 14 | 21 | 158 | 271 |
| Fixed Assets + | 6 | 8 | 92 | 152 |
| CWIP | 4 | 4 | 16 | 45 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets + | 4 | 9 | 50 | 73 |
| Total Assets | 14 | 21 | 158 | 271 |
Financials of Qualitek Labs
Cash Flows
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 1 | -5 | 10 | 15 |
| Cash from Investing Activity + | -6 | -2 | -60 | -51 |
| Cash from Financing Activity + | 5 | 7 | 54 | 37 |
| Net Cash Flow | 0 | -0 | 4 | 1 |
| Free Cash Flow | -5 | -7 | -13 | -32 |
| CFO/OP | 244% | -363% | 75% | 67% |
Financials of Qualitek Labs
Ratios
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 69 | 67 | 150 | 124 |
| Inventory Days | 70 | |||
| Days Payable | 206 | |||
| Cash Conversion Cycle | 69 | 67 | 150 | -13 |
| Working Capital Days | -701 | -432 | 25 | -10 |
| ROCE % | 6% | 12% |
Momentum score · price trend
38 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +15.3% | 71% |
| Last 6 months | +36.1% | 85% |
| Last 3 months | +1.9% | 71% |
The price is 24.2% below its all-time high of ₹646.4 (24 Sept 2026). Stocks more than 20% below their peak have their score halved, so 77 became 38.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Qualitek Labs: 0.4 × 71 + 0.4 × 85 + 0.2 × 71 = 77, halved to 38 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Qualitek Labs's management said in earlier quarters
Others in Commercial Services & Supplies this season
- Indiqube Spaces Ltd (Q2 FY27)
Q2 FY27 revenue from operations: ₹472 crore, up 34% YoY (₹350 crore in Q2 FY26) [Page 29, 9] . Key investor presentation takeaways from Indiqube Spaces Ltd's Q2
- EFC (I) (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹332.0 crore, up 30% year-on-year (Page 6, 36). Key investor presentation takeaways from EFC (I) Ltd's Q2 FY27 investor present
- Goyal Aluminiums (Q2 FY27)
Capex: INR 97 crore (approximate). Key results statement takeaways from Goyal Aluminiums Ltd's Q2 FY27 results statement — and how it ranks against sector peers
- Transwind Infrastructures (Q2 FY27)
776.92 lakhs (~68.2% growth). Key results statement takeaways from Transwind Infrastructures Ltd's Q2 FY27 results statement — and how it ranks against sector p